| Literature DB >> 9184229 |
A Muhlethaler-Mottet1, L A Otten, V Steimle, B Mach.
Abstract
The highly complex pattern of expression of major histocompatibility complex class II (MHC-II) molecules determines both the immune repertoire during development and subsequently the triggering and the control of immune responses. These distinct functions result from cell type-restricted expression, developmental control and either constitutive or inducible expression of MHC-II genes. Yet, in these various situations, MHC-II gene expression is always under the control of a unique transactivator, CIITA. Here we show that the CIITA gene is controlled by several distinct promoters, two of which direct specific constitutive expression in dendritic cells and B lymphocytes respectively, while another mediates gamma-interferon-induced expression. Thus the cellular, temporal and functional diversity of MHC-II expression is ultimately controlled by differential activation of different promoters of a single transactivator gene. This provides novel experimental tools to dissect compartment-specific gain or loss of MHC-II function in vivo.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9184229 PMCID: PMC1169893 DOI: 10.1093/emboj/16.10.2851
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598